Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 69
Filter
1.
Toxicol Lett ; 293: 207-215, 2018 Sep 01.
Article in English | MEDLINE | ID: mdl-29129798

ABSTRACT

Post-exposure nerve agent treatment usually includes administration of an oxime, which acts to restore function of the enzyme acetylcholinesterase (AChE). For immediate treatment of military personnel, this is usually administered with an autoinjector device, or devices containing the oxime such as pralidoxime, atropine and diazepam. In addition to the autoinjector, it is likely that personnel exposed to nerve agents, particularly by the percutaneous route, will require further treatment at medical facilities. As such, there is a need to understand the relationship between dose rate, plasma concentration, reactivation of AChE activity and efficacy, to provide supporting evidence for oxime infusions in nerve agent poisoning. Here, it has been demonstrated that intravenous infusion of HI-6, in combination with atropine, is efficacious against a percutaneous VX challenge in the conscious male Dunkin-Hartley guinea-pig. Inclusion of HI-6, in addition to atropine in the treatment, improved survival when compared to atropine alone. Additionally, erythrocyte AChE activity following poisoning was found to be dose dependent, with an increased dose rate of HI-6 (0.48mg/kg/min) resulting in increased AChE activity. As far as we are aware, this is the first study to correlate the pharmacokinetic profile of HI-6 with both its pharmacodynamic action of reactivating nerve agent inhibited AChE and with its efficacy against a persistent nerve agent exposure challenge in the same conscious animal.


Subject(s)
Chemical Warfare Agents/poisoning , Cholinesterase Reactivators/therapeutic use , Nerve Agents/poisoning , Organothiophosphorus Compounds/antagonists & inhibitors , Organothiophosphorus Compounds/poisoning , Oximes/therapeutic use , Pyridinium Compounds/therapeutic use , Acetylcholinesterase/blood , Acetylcholinesterase/metabolism , Animals , Atropine/pharmacology , Cholinesterase Reactivators/administration & dosage , Cholinesterase Reactivators/pharmacokinetics , Dose-Response Relationship, Drug , Guinea Pigs , Infusions, Intravenous , Male , Muscarinic Antagonists/pharmacology , Organothiophosphorus Compounds/administration & dosage , Oximes/administration & dosage , Oximes/pharmacokinetics , Pyridinium Compounds/administration & dosage , Pyridinium Compounds/pharmacokinetics , Survival Analysis
2.
Gene Ther ; 22(11): 856-65, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26125605

ABSTRACT

Helper-dependent adenoviral (HDA) vectors constitute excellent gene therapy tools for metabolic liver diseases. We have previously shown that an HDA vector encoding human porphobilinogen deaminase (PBGD) corrects acute intermittent porphyria mice. Now, six non-human primates were injected in the left hepatic lobe with the PBGD-encoding HDA vector to study levels and persistence of transgene expression. Intrahepatic administration of 5 × 10(12) viral particles kg(-1) (10(10) infective units kg(-1)) of HDA only resulted in transient (≈14 weeks) transgene expression in one out of three individuals. In contrast, a more prolonged 90-day immunosuppressive regimen (tacrolimus, mycophenolate, rituximab and steroids) extended meaningful transgene expression for over 76 weeks in two out of two cases. Transgene expression under immunosuppression (IS) reached maximum levels 6 weeks after HDA administration and gradually declined reaching a stable plateau within the therapeutic range for acute porphyria. The non-injected liver lobes also expressed the transgene because of vector circulation. IS controlled anticapsid T-cell responses and decreased the induction of neutralizing antibodies. Re-administration of HDA-hPBGD at week +78 achieved therapeutically meaningful transgene expression only in those animals receiving IS again at the time of this second vector exposure. Overall, immunity against adenoviral capsids poses serious hurdles for long-term HDA-mediated liver transduction, which can be partially circumvented by pharmacological IS.


Subject(s)
Adenoviridae/genetics , Gene Transfer Techniques , Helper Viruses/genetics , Immunosuppressive Agents/pharmacology , Liver/physiology , Transgenes , Animals , Gene Expression , Genetic Therapy/methods , Genetic Vectors/administration & dosage , Genetic Vectors/genetics , Humans , Hydroxymethylbilane Synthase/biosynthesis , Hydroxymethylbilane Synthase/genetics , Liver/metabolism , Macaca fascicularis , Male
3.
Phys Chem Chem Phys ; 14(39): 13638-45, 2012 Oct 21.
Article in English | MEDLINE | ID: mdl-22964845

ABSTRACT

Ultrafast transient absorption spectroscopy is used to investigate the exciton dynamics of Type II ZnTe-ZnSe core-shell colloidal quantum dots. Surface-trapping is shown to occur within a few picosecond for hot electrons and with a few 10s of picoseconds for electrons cooled to the band-edge, and is the dominant process in the decay of the band-edge bleach for well-stirred samples pumped at moderate powers. The surface-trapped electrons produce a broad photo-induced absorption that spectrally overlaps with the band-edge, distorting and partially cancelling out the bleach feature. At high pump powers and for unstirred samples, these surface-trapped electrons can survive sufficiently long within the pumped volume to accumulate under repeated excitation of the sample, resulting in the formation of an additional exciton decay channel.

4.
Inhal Toxicol ; 22(14): 1135-43, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21083508

ABSTRACT

CONTEXT: Inhalation of sulfur mustard (HD) vapor can cause life-threatening lung injury for which there is no specific treatment. A reproducible, characterized in vivo model is required to investigate novel therapies targeting HD-induced lung injury. MATERIALS AND METHODS: Anesthetized, spontaneously breathing large white pigs (~50 kg) were exposed directly to the lung to HD vapor at 60, 100, or 150 µg/kg, or to air, for ~10 min, and monitored for 6 h. Cardiovascular and respiratory parameters were recorded. Blood and bronchoalveolar lavage fluid (BALF) were collected to allow blood gas analysis, hematology, and to assay for lung inflammatory cells and mediators. Urine was collected and analyzed for HD metabolites. Histopathology samples were taken postmortem (PM). RESULTS: Air-exposed animals maintained normal lung physiology whilst lying supine and spontaneously breathing. There was a statistically significant increase in shunt fraction across all three HD-exposed groups when compared with air controls at 3-6 h post-exposure. Animals were increasingly hypoxemic with respiratory acidosis. The monosulfoxide ß-lyase metabolite of HD (1-methylsulfinyl-2-[2(methylthio)ethylsulfonyl)ethane], MSMTESE), was detected in urine from 2 h post-exposure. Pathological examination revealed necrosis and erosion of the tracheal epithelium in medium and high HD-exposed groups. CONCLUSION: These findings are consistent with those seen in the early stages of acute lung injury (ALI).


Subject(s)
Disease Models, Animal , Inhalation Exposure/adverse effects , Mustard Gas/administration & dosage , Mustard Gas/toxicity , Acute Lung Injury/chemically induced , Acute Lung Injury/pathology , Age Factors , Animals , Dose-Response Relationship, Drug , Female , Mustard Gas/metabolism , Oxyhemoglobins/metabolism , Respiratory Mucosa/drug effects , Respiratory Mucosa/pathology , Swine , Time Factors
6.
J Chromatogr B Analyt Technol Biomed Life Sci ; 878(17-18): 1253-6, 2010 May 15.
Article in English | MEDLINE | ID: mdl-20034857

ABSTRACT

VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methylphosphonothiolate) is a low volatility organophosphorus (OP) nerve agent and therefore the most likely route of exposure is via percutaneous absorption. Microdialysis has been used as a tool to study percutaneous poisoning by VX in the anesthetised guinea pig. A liquid chromatography tandem mass spectrometry (LC-MS-MS) method using positive electrospray ionisation (ESI) was used to quantitate VX in microdialysate samples collected from microdialysis probes, implanted into a blood vessel of anesthetised guinea pigs. The method resulted from modification of a LC-MS-MS method previously developed for the analysis of dermal microdialysates. Modification increased the sensitivity of the method, allowing quantitation of the trace levels of VX in blood microdialysates, over the range 0.002-1 ng/ml, with linear calibration. Quantitative results have been used to determine the time course of VX concentrations in the blood of guinea pigs following percutaneous poisoning.


Subject(s)
Chemical Warfare Agents/analysis , Chromatography, Liquid/methods , Organothiophosphorus Compounds/blood , Tandem Mass Spectrometry/methods , Administration, Cutaneous , Animals , Chemical Warfare Agents/pharmacokinetics , Dialysis , Drug Stability , Guinea Pigs , Linear Models , Organothiophosphorus Compounds/administration & dosage , Organothiophosphorus Compounds/pharmacokinetics , Reproducibility of Results , Sensitivity and Specificity
7.
Br J Cancer ; 100(7): 1111-9, 2009 Apr 07.
Article in English | MEDLINE | ID: mdl-19277038

ABSTRACT

Vascular endothelial growth factor (VEGF) inhibits differentiation and maturation of dendritic cells (DC), suggesting a potential immunosuppressive role for this proangiogenic factor. Bevacizumab, sorafenib and sunitinib target VEGF-mediated angiogenesis and are active against several types of cancer, but their effects on the immune system are poorly understood. In this study, VEGF and supernatants of renal carcinoma cell lines cultured under hypoxia were found to alter the differentiation of human monocytes to DC. Resulting DC showed impaired activity, as assessed by the alloreactive mixed T-lymphocyte reaction. Bevacizumab and sorafenib, but not sunitinib, reversed the inhibitory effects of VEGF, but not of those mediated by tumour supernatants. Dendritic cells matured under the influence of VEGF expressed less human leukocyte antigen-DR (HLA-DR) and CD86, and this effect was restored by bevacizumab and sorafenib. Finally, tumour-cell supernatants decreased interleukin-12 (IL-12) production by mature DC, and such inhibition was not restored by any of the tested drugs, delivered either as single agents or in combination. The deleterious effects of tumour-cell supernatants were mainly mediated by thermostable molecules distinct from VEGF. These results indicate that inhibition of the differentiation of monocytes to DC is a multifactorial effect, and that they support the development of combinations of angiogenesis inhibitors with immunological modulators.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Antibodies, Monoclonal/pharmacology , Antineoplastic Agents/pharmacology , Benzenesulfonates/pharmacology , Carcinoma, Renal Cell/drug therapy , Dendritic Cells/drug effects , Indoles/pharmacology , Kidney Neoplasms/drug therapy , Monocytes/cytology , Pyridines/pharmacology , Pyrroles/pharmacology , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal, Humanized , Benzenesulfonates/administration & dosage , Bevacizumab , Carcinoma, Renal Cell/pathology , Cell Differentiation , Cell Line, Tumor , Dendritic Cells/cytology , Humans , Indoles/administration & dosage , Interleukin-12/biosynthesis , Kidney Neoplasms/pathology , Lymphocyte Activation , Lymphocyte Culture Test, Mixed , Niacinamide/analogs & derivatives , Phenylurea Compounds , Pyridines/administration & dosage , Pyrroles/administration & dosage , Sorafenib , Sunitinib , T-Lymphocytes/immunology
8.
Gene Ther ; 16(1): 136-41, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18668147

ABSTRACT

Non-invasive in vivo imaging of transgene expression is currently providing very important means to optimize gene therapy regimes. Results in non-human primates are considered the most predictive models for the outcome in patients. In this study, we have documented that tumour and primary cell lines from human and non-human primates are comparably gene-transduced in vitro by serotype 5 adenovirus expressing HSV1-thymidine kinase. Transgene expression can be quantified in human and monkey cultured cells by positron emission tomography (PET) imaging when transduced cells are incubated with a fluoride-18 labelled penciclovir analogue. In our hands, PET images of cell cultures estimate the number of transduced cells rather than intensity of transgene expression once a threshold of TK per cell is reached. Interestingly, in vivo systemic administration of a clinical grade recombinant adenovirus expressing TK into macaques gives rise to an intense retention of the radiotracer in the liver parenchyma, providing an experimental system to visualize transgene expression that ought to be similar in human and macaques. Such imaging methodology might contribute to improve strategies based on adenoviral vectors.


Subject(s)
Genetic Therapy/methods , Herpesvirus 1, Human/enzymology , Liver/diagnostic imaging , Liver/enzymology , Positron-Emission Tomography , Thymidine Kinase/genetics , Acyclovir/analogs & derivatives , Acyclovir/pharmacology , Adenoviridae/genetics , Animals , Cell Count , Cell Line, Transformed , Gene Expression , Genetic Vectors/administration & dosage , Genetic Vectors/genetics , Guanine , Humans , Injections, Intravenous , Macaca , Models, Animal , Positron-Emission Tomography/methods , Radiopharmaceuticals/pharmacology , Transduction, Genetic/methods , Transgenes
9.
Gene Ther ; 15(7): 473-83, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18273053

ABSTRACT

The surface phenotype CD3-NK1.1+DX5+CD11c(int)B220+GR1- has been recently ascribed to a novel subset of mouse leukocytes termed interferon (IFN)-producing killer dendritic cells (IKDCs) that shares functions with natural killer (NK) cells and DCs. Interleukin-15 (IL-15) is critical for NK cells but its relationship with IKDC remained unexplored. An expression cassette encoding human IL-15 (hIL-15) has been transferred by hydrodynamic injection into the liver of mice, resulting in transient expression of the cytokine that is detectable during the first 48 h. hIL-15 hydrodynamic gene transfer resulted in an expansion of NK cells and IKDCs. Relative expansions of IKDCs were more dramatic in the IL-15 gene-transferred hepatic tissue than in the spleen. Adoptively transferred DX5+ cells comprising both NK cells and IKDCs proliferated in response to hydrodynamic injection of hIL-15, indicating that quantitative increases are at least in part the result of proliferation from already differentiated cells. Expansion is accompanied by enhanced cytolytic activity and increased expression of TRAIL and CD137 (4-1BB), without augmenting interferon-gamma production. The effects of a single hydrodynamic injection surpassed those of two intraperitoneal doses of the recombinant protein. The novel functional link between circulating IL-15 and IKDCs opens new possibilities to study the biology and applications of this minority cell subset.


Subject(s)
Genetic Therapy/methods , Interleukin-15/genetics , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Liver/immunology , Adoptive Transfer , Animals , Cytotoxicity, Immunologic , Dendritic Cells/immunology , Flow Cytometry , Genes, RAG-1 , Humans , Injections, Intravenous , Interleukin-15/metabolism , Lymphocyte Count , Mice , Mice, Inbred C57BL , Mice, Knockout , Recombinant Proteins , Reverse Transcriptase Polymerase Chain Reaction , Spleen/immunology , Transfection/methods
10.
Inmunología (1987) ; 26(3): 121-126, jul.-sept. 2007. ilus
Article in En | IBECS | ID: ibc-62527

ABSTRACT

Las células mieloides supresoras (Myeloid-derived suppressorcells, MDSC) pertenecen a un subtipo de leucocitos causantes deinmunosupresión en individuos portadores de tumor. En ratones,estas células han sido definidas como CD11b+GR1+IL-4Rá+y, debido a la presencia de tumores en modelos experimentales,se acumulan tanto en la lesión tumoral como en los órganos linfoides.CD137 (4-1BB) es un receptor de coestímulo de la familia dereceptores del factor de necrosis tumoral (TNF) principalmenteexpresado sobre la membrana de linfocitos T y de células NK(Natural Killer) activados, aunque también se encuentra en la superficiede otros leucocitos de estirpe mieloide como mastocitos, granulocitos,macrófagos, células dendríticas y endotelio. Anticuerposagonistas frente a CD137 incrementan la respuesta inmuneantitumoral potenciando los CTLs antitumorales. En este trabajo,células de carcinoma de colon C26 transfectadas para expresarGM-CSF se inocularon por vía subcutánea a ratones singénicosdebido a sus propiedades inductoras de un gran aumento enel número de las MDSCs. Mediante citometría de flujo multicolorhemos confirmado un notable aumento en el número de estascélulas CD11b+GR1+IL-4Rá+ tanto en el estroma tumoral comoen el bazo de los ratones portadores de tumor. La expresión deCD137 en este subtipo celular sin embargo, mostró resultadosnegativos. Por tanto, se pueden excluir los efectos directos de losmAbs sobre MDSCs como mecanismo de acción de la inmunoterapiacon anticuerpos anti-CD137. Según esto las terapias dirigidasa disminuir el número o función de MDSCs podrían sinergizarcon anticuerpos inmunoterapéuticos anti-CD137 ya queactúan sobre dianas diferentes


Myeloid-derived suppressor cells (MDSC) are a subset ofleukocytes associated with local and systemic T-cell immunosuppressionin tumor-bearing hosts. In mice these cells are bestdefined as CD11b+GR1+IL-4Rá+ and their numbers increase inresponse to the presence of an experimental malignancy both atthe tumor lesion and in lymphoid organs. CD137 is a co-stimulatoryreceptor that belongs to the tumor necrosis factor (TNF)receptor family characteristically expressed on activated T cellsand NK cells. Its expression has also been reported on myeloidcells such as mastocytes, granulocytes, macrophages, dendriticcells, and on endothelium. Agonist antibodies against CD137 areknown to increase the antitumor immune response through augmentingthe intensity of antitumor CTLs. In this study C26 coloncarcinoma cells transfected to express GM-CSF were subcutaneouslyimplanted in syngeneic mice because of its properties asthe most potent inducer of MDSCs. Indeed, multicolor flow cytometryconfirmed a dramatic numeric increase in CD11b+GR1+IL-4Rá+ cells both in the tumor stroma and in the spleen of tumorbearingmice. Analysis of CD137 expression on this cell subsetrendered completely negative results. Therefore direct effects ofimmunotherapeutic anti-CD137 monoclonal antibodies on MDSCscan be excluded as a mechanism of action, thus indicating thattherapies aimed at decreasing MDSCs might synergize withimmunotherapeutic anti-CD137 antibody as a result of dealing with different targets


Subject(s)
Animals , Rats , Immunosuppression Therapy/methods , Myeloid Cells/immunology , Antigens, Surface/analysis , T-Lymphocytes/immunology , Myelopoiesis , Neoplasms/immunology
11.
Lancet ; 362(9389): 1017-21, 2003 Sep 27.
Article in English | MEDLINE | ID: mdl-14522531

ABSTRACT

BACKGROUND: Polycystic ovary syndrome is the most common cause of anovulatory infertility. It has long-term health implications and is an important risk factor for type 2 diabetes. However, little is known about the cause of polycystic ovaries. We have used detailed morphological analysis to assess the hypothesis that there is an intrinsic ovarian abnormality that affects the earliest stages of follicular development. METHODS: We took small cortical biopsies during routine laparoscopy from 24 women with normal ovaries and regular cycles and from 32 women with polycystic ovaries, 16 of whom had regular, ovulatory cycles and 16 of whom had oligomenorrhoea. We used computerised image analysis to assess the density and developmental stage of small preantral follicles in serial sections of fixed tissue. FINDINGS: Median density of small preantral follicles, including those at primordial and primary stages, was six-fold greater in biopsies from polycystic ovaries in anovulatory women than in normal ovaries (p=0.009). In both ovulatory and anovulatory women with polycystic ovaries, we noted a significant increase in the percentage of early growing (primary) follicles and a reciprocal decrease in the proportion of primordial follicles compared with normal ovaries. INTERPRETATION: Our findings indicate that there are fundamental differences between polycystic and normal ovaries in early follicular development, suggesting an intrinsic ovarian abnormality. The increased density of small preantral follicles in polycystic ovaries could result from increased population of the fetal ovary by germ cells, or from decreased rate of loss of oocytes during late gestation, childhood, and puberty.


Subject(s)
Ovarian Follicle/pathology , Polycystic Ovary Syndrome/pathology , Adult , Biopsy , Female , Humans , Luteal Phase/physiology , Oligomenorrhea/pathology , Ovarian Follicle/diagnostic imaging , Ovarian Follicle/growth & development , Ovulation/physiology , Polycystic Ovary Syndrome/diagnostic imaging , Ultrasonography
12.
J Clin Microbiol ; 39(10): 3555-62, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11574572

ABSTRACT

Amplified 16S ribosomal DNA (rDNA) restriction analysis (ARDRA), using enzymes HaeIII and HpaII, was applied to 176 fresh and 299 stored clinical isolates of putative Actinomyces spp. referred to the Anaerobe Reference Unit of the Public Health Laboratory Service for confirmation of identity. Results were compared with ARDRA results obtained previously for reference strains and with conventional phenotypic reactions. Identities of some strains were confirmed by analysis of partial 16S rDNA sequences. Of the 475 isolates, 331 (70%) were clearly assigned to recognized Actinomyces species, including 94 isolates assigned to six recently described species. A further 52 isolates in 12 ARDRA profiles were designated as apparently resembling recognized species, and 44 isolates, in 18 novel profiles, were confirmed as members of genera other than Actinomyces. The identities of 48 isolates in nine profiles remain uncertain, and they may represent novel species of Actinomyces. For the majority of species, phenotypic results, published reactions for the species, and ARDRA profiles concurred. However, of 113 stored isolates originally identified as A. meyeri or resembling A. meyeri by phenotypic tests, only 21 were confirmed as A. meyeri by ARDRA; 63 were reassigned as A. turicensis, 7 as other recognized species, and 22 as unidentified actinomycetes. Analyses of incidence and clinical associations of Actinomyces spp. add to the currently sparse knowledge of some recently described species.


Subject(s)
Actinomyces/classification , Actinomycosis/microbiology , DNA, Ribosomal/genetics , RNA, Ribosomal, 16S/genetics , Ribotyping , Actinomyces/genetics , DNA, Bacterial/genetics , Deoxyribonuclease HpaII/metabolism , Deoxyribonucleases, Type II Site-Specific/metabolism , Humans , Sequence Analysis, DNA
13.
J Virol ; 75(19): 9068-76, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11533170

ABSTRACT

Woodchuck hepatitis virus (WHV) and hepatitis B virus (HBV) are closely similar with respect to genomic organization, host antiviral responses, and pathobiology of the infection. T-cell immunity against viral nucleocapsid (HBcAg or WHcAg) has been shown to play a critical role in viral clearance and protection against infection. Here we show that vaccination of healthy woodchucks by gene gun bombardment with a plasmid coding for WHcAg (pCw) stimulates proliferation of WHcAg-specific T cells but that these cells do not produce significant levels of gamma interferon (IFN-gamma) upon antigen stimulation. In addition, animals vaccinated with pCw alone were not protected against WHV inoculation. In order to induce a Th1 cytokine response, another group of woodchucks was immunized with pCw together with another plasmid coding for woodchuck interleukin-12 (IL-12). These animals exhibited WHcAg-specific T-cell proliferation with high IFN-gamma production and were protected against challenge with WHV, showing no viremia or low-level transient viremia after WHV inoculation. In conclusion, gene gun immunization with WHV core generates a non-Th1 type of response which does not protect against experimental infection. However, steering the immune response to a Th1 cytokine profile by IL-12 coadministration achieves protective immunity. These data demonstrate a crucial role of Th1 responses in the control of hepadnavirus replication and suggest new approaches to inducing protection against HBV infection.


Subject(s)
Hepatitis B Virus, Woodchuck/immunology , Hepatitis B/immunology , Hepatitis B/prevention & control , Interleukin-12/immunology , Nucleocapsid/immunology , Animals , Biolistics , Hepatitis B/virology , Hepatitis B Virus, Woodchuck/genetics , Interleukin-12/genetics , Marmota , Nucleocapsid/genetics , T-Lymphocytes/immunology , Viral Vaccines
14.
J Hepatol ; 35(1): 105-11, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11495027

ABSTRACT

BACKGROUND/AIMS: Immunotherapy of patients chronically-infected with hepatitis B virus (HBV) may have the risk of fulminant hepatitis. This risk might be diminished if immunotherapy was carried out under conditions of low viremia. METHODS: Five woodchucks chronically-infected with woodchuck hepatitis virus (WHV), a virus closely related to HBV, were treated with lamivudine for 23 weeks. At week 10, when viremia had decreased by 3-5 logs, three woodchucks were vaccinated with woodchuck hepatitis virus surface antigen (WHsAg) plus the T-helper determinant FISEAIIHVLHSR. RESULTS: It was found that the administration of lamivudine only, had no effect on the T-helper response against WHV antigens. By contrast, vaccination induced T-helper responses against WHV antigens, shifting the cytokine profile from Th2 to Th0/Th1, but was without effect on viremia, WHsAg levels, or anti-WHs antibodies. Analysis of liver biopsies showed that lamivudine administration may have reduced hepatic inflammation. By contrast, vaccination clearly enhanced hepatic inflammation. After lamivudine withdrawal, viremia returned to high levels. CONCLUSIONS: These results suggest that therapeutic vaccination of chronically-infected woodchucks under conditions of low viremia shifts the cytokine profile against viral antigens towards Th0/Th1. This shift may prevent the efficient induction of anti-WHs antibodies.


Subject(s)
Antigens, Viral/immunology , Hepatitis B Virus, Woodchuck/immunology , Hepatitis B/therapy , Immunotherapy, Active , Lamivudine/therapeutic use , Marmota , Reverse Transcriptase Inhibitors/therapeutic use , T-Lymphocytes, Helper-Inducer/immunology , Animals , Chronic Disease , Hepatitis B/immunology , Hepatitis B/virology , Hepatitis B Virus, Woodchuck/drug effects , Liver/drug effects , Liver/pathology , Viral Load , Viremia/virology
15.
J Clin Microbiol ; 38(9): 3209-13, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10970359

ABSTRACT

Bacteroides spp. are opportunist pathogens that cause blood and soft tissue infections and are often resistant to antimicrobial agents. We have developed a combined PCR-restriction fragment length polymorphism (RFLP) technique to characterize the 16S rRNA gene for identification purposes and the nitroimidazole resistance (nim) gene for detection of resistance to the major antimicrobial agent used to treat Bacteroides infections: metronidazole (MTZ). PCR-RFLP analysis of 16S ribosomal (rDNA) with HpaII and TaqI produced profiles that enabled discrimination of type strains and identification of 70 test strains to the species level. The 16S rDNA PCR-RFLP identification results agreed with routine phenotypic testing for 62 of the strains. The discrepancies between phenotypic and PCR-RFLP methods for eight strains were resolved by 16S rDNA sequencing in three cases, but five strains remain unidentified. The presence of nim genes was indicated by PCR in 25 of 28 strains that exhibited reduced sensitivity to MTZ. PCR-RFLP of the nim gene products identified the four reported genes (nimA, -B, -C, and -D) and indicated the presence of a previously unreported nim gene in 5 strains. This novel nim gene exhibited 75% DNA sequence similarity with nimB. These rapid, accurate, and inexpensive methods should enable improved identification of Bacteroides spp. and the detection of MTZ resistance determinants.


Subject(s)
Bacteroides/classification , Bacteroides/drug effects , Nitroimidazoles/pharmacology , Polymerase Chain Reaction/methods , Polymorphism, Restriction Fragment Length , Anti-Bacterial Agents/pharmacology , Bacteroides/genetics , Bacteroides Infections/microbiology , Drug Resistance, Microbial/genetics , Genes, rRNA , Humans , Metronidazole/pharmacology , Microbial Sensitivity Tests , Molecular Sequence Data , Phenotype , RNA, Ribosomal, 16S/genetics
17.
FEMS Microbiol Lett ; 186(2): 307-12, 2000 May 15.
Article in English | MEDLINE | ID: mdl-10802189

ABSTRACT

In addition to the two large clostridial cytotoxins (TcdA and TcdB) certain strains of Clostridium difficile produce an actin-specific ADP-ribosyltransferase, or binary toxin. PCR reactions were developed to detect genes encoding the enzymatic (cdtA) and binding (cdtB) components of the binary toxin and 170 representative strains were tested to assess the prevalence of the toxin. Positive PCR results (n=59) were confirmed by immunoblotting and ADP-ribosyltransferase assay. PCR ribotype and toxinotype (restriction fragment length polymorphism analysis of genes for TcdA and TcdB) correlated with possession of binary toxin genes. All strains with cdtA and cdtB belonged to toxin-variable toxinotypes and five toxin-producing groups of strains have been described according to the presence or absence of TcdA, TcdB and binary toxin. Result indicate that ca. 6.4% of toxigenic isolates of C. difficile referred to the Anaerobe Reference Unit from UK hospitals have cdtA and cdtB genes.


Subject(s)
ADP Ribose Transferases , Bacterial Proteins , Bacterial Toxins/metabolism , Clostridioides difficile/enzymology , Clostridioides difficile/genetics , Poly(ADP-ribose) Polymerases/metabolism , Actins/metabolism , Bacterial Toxins/genetics , Phylogeny , Poly(ADP-ribose) Polymerases/genetics , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length , Substrate Specificity
19.
J Med Microbiol ; 48(11): 1017-1022, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10535646

ABSTRACT

A specific 16S rDNA PCR and subsequent hybridisation reaction was designed to discriminate between strains of Prevotella intermedia (n = 15) and P. nigrescens (n = 15). This technique was then used to detect the presence of these two bacterial species in acute suppurative oral infection. A total of 36 pus samples aspirated from 26 peri-apical abscesses, three root canals, three periodontal abscesses, two cases of refractory periodontitis, one cyst and one haematoma was examined. A portion of the pus sample was processed by PCR and the remainder of the specimen was subjected to routine culture. The PCR-based technique gave an identical pattern of detection of P. intermedia or P. nigrescens to that obtained by culture for 30 of the 36 specimens. Either P. intermedia or P. nigrescens was present in 14 samples and neither species was detected in 16 samples. In the remaining six samples the PCR method indicated the presence of one (n = 3) or both (n = 3) of the Prevotella species but neither or only one species was isolated by culture. It is concluded that the presence of P. intermedia and P. nigrescens in pus can be detected rapidly and specifically by direct PCR amplification of 16S rDNA. P. nigrescens was detected more frequently than P. intermedia in suppurative peri-apical infection both by culture and PCR.


Subject(s)
Bacteroidaceae Infections/microbiology , DNA, Ribosomal/analysis , Periodontitis/microbiology , Prevotella intermedia/isolation & purification , Prevotella/isolation & purification , RNA, Ribosomal, 16S/genetics , Bacteroidaceae Infections/diagnosis , DNA Primers/chemistry , DNA, Bacterial/analysis , Humans , Nucleic Acid Hybridization , Periapical Abscess/diagnosis , Periapical Abscess/microbiology , Periodontal Abscess/diagnosis , Periodontal Abscess/microbiology , Periodontitis/diagnosis , Polymerase Chain Reaction , Prevotella/genetics , Prevotella intermedia/genetics , Pulpitis/diagnosis , Pulpitis/microbiology , RNA, Bacterial/genetics , Reproducibility of Results , Suppuration/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...